30.1 C
New York
Sunday, June 7, 2026

Tag: trial

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors It Has Filed a Complaint to Recover Losses Suffered by Purchasers of GRAIL, Inc. Common Stock...

NEW YORK, June 05, 2026 (GLOBE NEWSWIRE) -- The following statement is being issued by Levi & Korsinsky, LLP:

BTC/USD Nears $60,000 as AIX Alpha’s 10,000 Market Simulations Reveal What Comes Next

LOS ANGELES, June 05, 2026 (GLOBE NEWSWIRE) -- Bitcoin is approaching one of its most closely watched price levels of 2026, with BTC/USD hovering near the $60,000 threshold as volatility continues to pressure digital asset markets.

Pudu Robotics Unveils PuduFM 1.0 and PuduAgent: Defining the Next Era of Humanoid and Embodied AI Systems

Pudu Robotics launches PuduFM 1.0 & PuduAgent, enabling "One Brain, Multiple Embodiments" for scalable service robots across industries.

Altesa BioSciences Presents New Phase 2 Vapendavir Challenge Study Results at 2026 American Society for Microbiology (ASM) Microbe Conference

New clinical findings further reinforce therapeutic potential of vapendavir as targeted approach to preventing rhinovirus-driven COPD exacerbationsWASHINGTON, June 5, 2026 /PRNewswire/ -- Altesa BioSciences, a...

PXN Unveils All-New High-Linearity Modular NAVOS Flight Series at FlightSimExpo 2026

Complete Civil Aviation Yoke System + Combat HOTAS Ecosystem – With Innovative Expansion Roadmap, Beginner-Friendly Software, and Thoughtful Design DetailsST. PAUL, Minn., June 5,...

$WIX Stock Notification: Lose Money on Your Wix Investment? Contact BFA Law about its Ongoing Securities Fraud Investigation

Lose Money on Your Wix Investment? Contact BFA Law about its Ongoing Securities Fraud Investigation

UTGL Donates HK$650,000 to Advance Anti-Aging, Cardiovascular Health and Healthy Longevity Through Corporate Social Responsibility and Clinical Research

HONG KONG, June 5, 2026 /PRNewswire/ -- UniTrust Global Limited | UTGL announced a donation of HK$650,000 to Prime Healthcare Medical Services Limited in...

Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR

The study showed that orelabrutinib was safe and well tolerated in participants with SLE.

Mabwell’s 9MW5211 Receives IND Clearance from NMPA for Inflammatory Bowel Disease

SHANGHAI, June 4, 2026 /PRNewswire/ -- Mabwell (688062.SH, 02493.HK), an innovation-driven biopharmaceutical company with a fully integrated industry chain, announced that its independently developed innovative...

Lundbeck presents positive Phase IIb data for bocunebart (Lu AG09222; anti-PACAP mAb) in migraine prevention at the AHS congress

The intravenous part of the Phase IIb clinical dose-finding trial PROCEED met its primary endpoint, with bocunebart demonstrating a statistically significant reduction in monthly...

MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial

MAIA’s novel telomere-targeting therapy being evaluated as a third-line treatment for advanced non-small cell lung cancer

Ocean Tomo, a Part of J.S. Held, Experts Named to the 2026 IAM Patent 1000

Intellectual Property disputes professionals named among the world's top experts by IAM.NEW YORK, June 4, 2026 /PRNewswire/ -- The 2026 IAM Patent 1000 has once...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsTrial